BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference

  July 3, 2024

   · 

  12 min read
• Business

  Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 02, 2024

  July 3, 2024

   · 

  1 min read
• Drug Development

  Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD

  July 3, 2024

   · 

  18 min read
• Business

  Pentixapharm Acquires Target Discovery Business of Glycotope

  July 3, 2024

   · 

  4 min read
• Business

  Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

  July 3, 2024

   · 

  20 min read
• Business

  MedMira Reports Third Quarter Results FY2024

  July 3, 2024

   · 

  4 min read
• Business

  Cartesian Therapeutics Strengthens Board of Directors with Appointment of Kemal Malik

  July 3, 2024

   · 

  6 min read
• Drug Development

  Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism

  July 3, 2024

   · 

  1 min read
• Drug Development

  Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - July 02, 2024

  July 3, 2024

   · 

  2 min read
• FDA

  FDA Roundup: July 2, 2024

  July 3, 2024

   · 

  3 min read